What's new

Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised

Jun 18, 2025 - 12:25
 0
Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir,...

Next Article

MBDA Reveals ‘One Way Effector’ Long Range Strike Drone

Related Posts

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0